Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cancer Genetics|April 6, 2021
Importance of conventional cytogenetics in the identification of ins(19;X)(q13.1;p11.2q28) and t(1;11)(q10;p10), both, novel cytogenetic abnormalities in a pediatric AML caseDhanlaxmi Shetty, Purvi Mohanty, Elizabeth Talker, et al.
American Journal of Blood Research|November 29, 2023
Intracranial disease in pediatric Hodgkin lymphoma-case report and review of literatureNidhi Dhariwal, Nirmalya Roy Moulik, Vasudeva Bhat, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2022
Clinicopathologic Profile and Treatment Outcomes of Children With Diffuse Large B-cell Lymphomas: Experience From a Tertiary Cancer Center in IndiaRadnyi Mande, Nirmalya Roy Moulik, Tanuja Shet, et al.
Pediatric Blood & Cancer|November 28, 2023
KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1Shyam Srinivasan, Chetan Dhamne, Nikhil Patkar, et al.
International Journal of Laboratory Hematology|August 13, 2021
Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)-A real-world contextShrinidhi Nathany, Gaurav Chatterjee, Shruti Ghai, et al.
Pediatric Blood & Cancer|September 1, 2020
Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in IndiaShyam Srinivasan, Nirmalya Roy Moulik, Anand Kc, et al.
Pediatric Hematology and Oncology|February 18, 2022
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in IndiaKalasekhar Vijayasekharan, Anand Kc, Maya Prasad, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in IndiaShyam Srinivasan, Mili Aggarwal, Nikhil Patkar, et al.
British Journal of Haematology|May 21, 2025
Combination of fixed low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical Hodgkin lymphomaShyam Srinivasan, Aditya Narayan, Chetan Dhamne, et al.
Journal De Mycologie Medicale|November 7, 2024
Prevalence and outcome of candidemia among paediatric cancer patients: A single centre experience from IndiaPoonam Khemani, Shyam Srinivasan, Gaurav Salunke, et al.
Pageof 7